Change Theme
Business Standard
Tue, Sep 3, 2024
Mankind Pharma plans Rs 9,000 crore raise for Bharat Serums acquisition
The move will position Mankind as a leader in the gynaecology-fertility segment, with an anticipated market share of around 20%, surpassing Emcure